Related Experiment Video
Updated: Jun 22, 2026
10:28
Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
Published on: December 5, 2017
Targeting the Nrf2 pathway against cardiovascular disease
Jinqing Li1, Tomonaga Ichikawa, Joseph S Janicki
1University of South Carolina School of Medicine, Department of Cell Biology and Anatomy, 6439 Garners Ferry Road, Columbia, SC 29208, USA.
Expert Opinion on Therapeutic Targets
|June 18, 2009
Summary
Nuclear factor E2-related factor 2 (Nrf2) protects the cardiovascular system by reducing oxidative stress. Targeting Nrf2 offers a promising therapeutic strategy for cardiovascular diseases.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Oxidative Stress Research
Background:
- Nuclear factor E2-related factor 2 (Nrf2) regulates antioxidant and detoxifying enzymes.
- Nrf2 is present throughout the cardiovascular system.
- Oxidative stress is a key factor in cardiovascular disease development.
Purpose of the Study:
- To review the literature on Nrf2's role in cardiovascular homeostasis.
- To highlight Nrf2 as a therapeutic target for cardiovascular diseases.
- To explore mechanisms of Nrf2-mediated cardioprotection.
Main Methods:
- Literature review of existing studies on Nrf2 and cardiovascular disease.
- Analysis of experimental data illustrating Nrf2 cardioprotective mechanisms.
Main Results:
- Nrf2 is a critical regulator of cardiovascular homeostasis.
- Nrf2 suppresses oxidative stress, mitigating cardiovascular disease.
- Several Nrf2 downstream genes contribute to cardiovascular protection.
Conclusions:
- Nrf2 plays a vital role in protecting the cardiovascular system.
- Nrf2 is a promising therapeutic target for treating cardiovascular diseases.
- Understanding Nrf2 mechanisms can lead to novel treatment strategies.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...